Perturbative and non perturbative effects in the Standard Model and orbifolded ADS/CFT based theories

We study some perturbative and nonperturbative effects in the framework of the Standard Model of particle physics. In particular we consider the time dependence of the Higgs vacuum expectation value given by the dynamics of the StandardModel and study the non-adiabatic production of both bosons and fermions, which is intrinsically non-perturbative. In theHartree approximation, we analyze the general expressions that describe the dissipative dynamics due to the backreaction of the produced particles. Then, we solve numerically some relevant cases for the Standard Model phenomenology in the regime of relatively small oscillations of the Higgs vacuum expectation value (vev). As perturbative effects, we consider the leading logarithmic resummation in small Bjorken x QCD, concentrating ourselves on the Nc dependence of the Green functions associated to reggeized gluons. Here the eigenvalues of the BKP kernel for states of more than three reggeized gluons are unknown in general, contrary to the large Nc limit (planar limit) case where the problem becomes integrable. In this contest we consider a 4-gluon kernel for a finite number of colors and define some simple toy models for the configuration space dynamics, which are directly solvable with group theoretical methods. In particular we study the depencence of the spectrum of thesemodelswith respect to the number of colors andmake comparisons with the planar limit case. In the final part we move on the study of theories beyond the Standard Model, considering models built on AdS5 S5/Γ orbifold compactifications of the type IIB superstring, where Γ is the abelian group Zn. We present an appealing three family N = 0 SUSY model with n = 7 for the order of the orbifolding group. This result in a modified Pati–Salam Model which reduced to the StandardModel after symmetry breaking and has interesting phenomenological consequences for LHC.

Studio di marcatori biologici prognostici nel linfoma di Hodgkin

Recent reports showed that early-interim PET-scan is the only tool predicting treatment outcome in advanced-stage classical Hodgkin lymphoma (asCHL). We evaluated the prognostic impact of a series of immunohistochemical markers, mentioned in literature as prognostic factors, on tissue microarrays assembled from biopsies of 220 patients: STAT1, SAP, TOP2A, PCNA and CD20, both in neoplastic (HRSC) and microenvironment cells (MC); RRM2, MAD2, CDC2, BCL2, P53, BCL11A and EBER in HRSC; ALDH1A1, TIA-1, granzyme B, perforin, FOXP3, and PD-1 in MC. All patients had been treated with standard ABVD ± Rx therapy. Interim-PET after 2 ABVD courses was evaluated according to the criteria indicated by Gallamini in his study (Journal of Clinical Oncology, 2007). The survival analysis has been performed in a subset of 138 patients whose complete clinical information were available: the mean age was 33.3 years (14-79), the stage III-IVB in 98 and IIB in 40, and the mean follow-up 38.1 months (7.6-71.9). Histopathology review showed: NS-I 75, NS-II 22, MC 20, DL 3, and CHL/nos 18 cases. Interim-PET was positive in 30 patients, while treatment failure was recorded in 32. In univariate analysis the factors related to treatment outcome were BCL2 on HRSC (cut-off value 50%), STAT1/SAP on MC, and PET (Log-rank 6.9, 7.9 and 93.9 respectively). The combined expression of STAT1 and SAP was scored in three levels depending on the architectural pattern: score 0 for expression of both with a diffuse/rosetting pattern; score 1 for discordant combination of diffuse/rosetting and scattered patterns; score 2 for both markers with a scattered pattern; the 3y-PFS were 87.4%, 69.9% and 61.9% respectively. In multivariate analysis PET, BCL2 and STAT1/SAP remained significant (HR: 24.8, 4.6, 7.5 and 5.6, respectively; p<.01). The proposed model is able to predict treatment response in AsCHL, even if with a lower efficacy than PET. However, unlike PET, it can be applied upfront therapy.